Total Payments
$222,861
2024 Payments
$136.19
Companies
20
Transactions
412
Payment Breakdown by Category
Other$151,573 (68.0%)
Consulting$40,145 (18.0%)
Travel$17,303 (7.8%)
Food & Beverage$13,591 (6.1%)
Education$158.97 (0.1%)
Gifts$90.17 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $151,573 | 67 | 68.0% |
| Consulting Fee | $40,145 | 12 | 18.0% |
| Travel and Lodging | $17,303 | 77 | 7.8% |
| Food and Beverage | $13,591 | 251 | 6.1% |
| Education | $158.97 | 4 | 0.1% |
| Gift | $90.17 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $159,401 | 203 | $0 (2023) |
| Gilead Sciences, Inc. | $57,514 | 122 | $0 (2024) |
| Ethicon US, LLC | $952.14 | 10 | $0 (2024) |
| AbbVie Inc. | $932.30 | 12 | $0 (2020) |
| GlaxoSmithKline, LLC. | $850.37 | 9 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $439.56 | 11 | $0 (2020) |
| Napo Pharmaceuticals Inc | $392.83 | 5 | $0 (2020) |
| Bovie Medical Corporation | $382.11 | 3 | $0 (2017) |
| Medtronic, Inc. | $350.14 | 2 | $0 (2023) |
| Apyx Medical Corporation | $303.23 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $136.19 | 2 | Ethicon US, LLC ($86.60) |
| 2023 | $467.25 | 3 | Medtronic, Inc. ($350.14) |
| 2022 | $3,900 | 1 | ViiV Healthcare Company ($3,900) |
| 2021 | $5,049 | 7 | ViiV Healthcare Company ($2,855) |
| 2020 | $45,970 | 46 | ViiV Healthcare Company ($40,588) |
| 2019 | $118,577 | 196 | ViiV Healthcare Company ($92,706) |
| 2018 | $26,522 | 87 | ViiV Healthcare Company ($12,526) |
| 2017 | $22,240 | 70 | Gilead Sciences Inc ($14,150) |
All Payment Transactions
412 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | Ethicon US, LLC | Enseal (Device) | Food and Beverage | In-kind items and services | $86.60 | General |
| Category: Energy | ||||||
| 08/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $49.59 | General |
| 10/18/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $117.11 | General |
| Category: HIV | ||||||
| 10/06/2023 | Medtronic, Inc. | LIGASURE (Device) | Food and Beverage | In-kind items and services | $175.14 | General |
| Category: Vessel Sealing | ||||||
| 01/20/2023 | Medtronic, Inc. | LIGASURE (Device) | Food and Beverage | In-kind items and services | $175.00 | General |
| Category: Vessel Sealing | ||||||
| 04/05/2022 | ViiV Healthcare Company | DOVATO (Drug) | Consulting Fee | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 12/20/2021 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $420.00 | General |
| Category: HIV | ||||||
| 09/15/2021 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,660.00 | General |
| Category: HIV | ||||||
| 06/11/2021 | Ethicon US, LLC | Enseal X1 (Device) | Food and Beverage | In-kind items and services | $114.01 | General |
| Category: Energy | ||||||
| 05/11/2021 | ViiV Healthcare Company | DOVATO (Drug), CABENUVA, RUKOBIA | Food and Beverage | In-kind items and services | $37.16 | General |
| Category: HIV | ||||||
| 04/20/2021 | ViiV Healthcare Company | DOVATO (Drug) | Consulting Fee | Cash or cash equivalent | $2,760.00 | General |
| Category: HIV | ||||||
| 03/12/2021 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: HIV | ||||||
| 02/26/2021 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: HIV | ||||||
| 12/08/2020 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: HIV | ||||||
| 12/07/2020 | Gilead Sciences, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $350.00 | General |
| 11/22/2020 | ViiV Healthcare Company | DOVATO (Drug) | Consulting Fee | Cash or cash equivalent | $3,680.00 | General |
| Category: HIV | ||||||
| 11/10/2020 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: HIV | ||||||
| 10/14/2020 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: HIV | ||||||
| 09/22/2020 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: HIV | ||||||
| 09/22/2020 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: HIV | ||||||
| 07/16/2020 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: HIV | ||||||
| 06/26/2020 | Gilead Sciences, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| 06/19/2020 | ViiV Healthcare Company | DOVATO (Drug) | Consulting Fee | Cash or cash equivalent | $3,680.00 | General |
| Category: HIV | ||||||
| 06/02/2020 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: HIV | ||||||
| 05/19/2020 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: HIV | ||||||
About Jocelyn Dee
Jocelyn Dee is a Internal Medicine healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053495663.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jocelyn Dee has received a total of $222,861 in payments from pharmaceutical and medical device companies, with $136.19 received in 2024. These payments were reported across 412 transactions from 20 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($151,573).
Ad
Practice Information
- Specialty Internal Medicine
- Location Los Angeles, CA
- Active Since 10/24/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1053495663
Products in Payments
- DOVATO (Drug) $109,988
- Biktarvy (Drug) $25,158
- JULUCA (Drug) $12,727
- Genvoya (Drug) $9,506
- TRIUMEQ (Drug) $1,936
- Descovy (Drug) $1,898
- TIVICAY (Drug) $960.39
- Lupron (Drug) $456.33
- ENSEAL Product Family (Device) $413.02
- Mytesi (Drug) $392.83
- Mavyret (Drug) $351.57
- LIGASURE (Device) $350.14
- Symtuza (Drug) $299.89
- ISENTRESS (Drug) $249.31
- PREZCOBIX (Drug) $240.90
- OFIRMEV (Drug) $188.00
- SDC (Device) $149.64
- LigaSure (Device) $133.38
- Valleylab (Device) $120.97
- ZEJULA (Drug) $120.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Los Angeles
Dr. Thomas Magee, Md, MD
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Dr. Julio Gutierrez, Md, MD
Internal Medicine — Payments: $920,439
Internal Medicine $920,439
Dr. Mohammad Kamgar, M.d, M.D
Internal Medicine — Payments: $471,176
Internal Medicine $471,176
Dr. Caroline Piatek, M.d,, M.D,
Internal Medicine — Payments: $468,526
Internal Medicine $468,526
Gottfried Konecny, Md, MD
Internal Medicine — Payments: $399,651
Internal Medicine $399,651
Dr. Elizabeth Volkmann, Md, MD
Internal Medicine — Payments: $397,666
Internal Medicine $397,666